{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:17:23Z","timestamp":1789903043627,"version":"4.0.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006728","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI-113266"],"award-info":[{"award-number":["R01-AI-113266"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["UL1TR001079"],"award-info":[{"award-number":["UL1TR001079"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["S10OD020091"],"award-info":[{"award-number":["S10OD020091"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001079"],"award-info":[{"award-number":["UL1 TR001079"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006728","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T17:25:16Z","timestamp":1534181116000},"page":"e0006728","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-7464","authenticated-orcid":true,"given":"Paul J.","family":"Converse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak V.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokeya","family":"Tasneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Ammerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Rudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques H.","family":"Grosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Nuermberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/AAC.00175-07","article-title":"Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli Ulcer (<italic>Mycobacterium ulcerans<\/italic> Disease)","volume":"51","author":"A Chauty","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2217\/fmb.11.101","article-title":"Treating <italic>Mycobacterium ulcerans<\/italic> disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?","volume":"6","author":"PJ Converse","year":"2011","journal-title":"Future Microbiology"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.49.8.3182-3186.2005","article-title":"Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of <italic>Mycobacterium ulcerans<\/italic> in Early Lesions of Buruli Ulcer in Humans","volume":"49","author":"S Etuaful","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"e2739","DOI":"10.1371\/journal.pntd.0002739","article-title":"Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial","volume":"8","author":"S Klis","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/imj.13511","article-title":"Antibiotic complications during the treatment of <italic>Mycobacterium ulcerans<\/italic> disease in Australian patients","volume":"47","author":"DP O\u2019Brien","year":"2017","journal-title":"Internal Medicine Journal"},{"key":"ref6","unstructured":"World Health Organization. Report from the Meeting of the Buruli ulcer Technical Advisory Group World Health Organization. Geneva, Switzerland: 2017 21 March 2017."},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"e0003823","DOI":"10.1371\/journal.pntd.0003823","article-title":"Efficacy of Rifampin Plus Clofazimine in a Murine Model of <italic>Mycobacterium ulcerans<\/italic> Disease","volume":"9","author":"PJ Converse","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref8","article-title":"Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis","author":"NC Ammerman","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/AAC.00260-15","article-title":"Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis","volume":"59","author":"RV Swanson","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/AAC.00912-12","article-title":"Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis","volume":"56","author":"IM Rosenthal","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pmed.0040344","article-title":"Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model","volume":"4","author":"IM Rosenthal","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"e0005066","DOI":"10.1371\/journal.pntd.0005066","article-title":"Sterilizing Activity of Fully Oral Intermittent Regimens against <italic>Mycobacterium ulcerans<\/italic> Infection in Mice","volume":"10","author":"A Chauffour","year":"2016","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5694\/j.1326-5377.2009.tb03313.x","article-title":"&quot;Paradoxical&quot; immune-mediated reactions to <italic>Mycobacterium ulcerans<\/italic> during antibiotic treatment: a result of treatment success, not failure","volume":"191","author":"DP O\u2019Brien","year":"2009","journal-title":"The Medical journal of Australia"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"e29774","DOI":"10.1371\/journal.pone.0029774","article-title":"Autoluminescent <italic>Mycobacterium tuberculosis<\/italic> for Rapid, Real-Time, Non-Invasive Assessment of Drug and Vaccine Efficacy","volume":"7","author":"T Zhang","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"e2598","DOI":"10.1371\/journal.pntd.0002598","article-title":"Rapid, Serial, Non-invasive Assessment of Drug Efficacy in Mice with Autoluminescent <italic>Mycobacterium ulcerans<\/italic> Infection","volume":"7","author":"T Zhang","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1371\/journal.pntd.0000985","article-title":"BCG-Mediated Protection against <italic>Mycobacterium ulcerans<\/italic> Infection in the Mouse","volume":"5","author":"PJ Converse","year":"2011","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/AAC.01260-10","article-title":"Using Bioluminescence To Monitor Treatment Response in Real Time in Mice with <italic>Mycobacterium ulcerans<\/italic> Infection","volume":"55","author":"T Zhang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1128\/AAC.46.10.3193-3196.2002","article-title":"Bactericidal activity of rifampin-amikacin against <italic>Mycobacterium ulcerans<\/italic> in mice","volume":"46","author":"H Dega","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1371\/journal.pntd.0000933","article-title":"Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against <italic>Mycobacterium ulcerans<\/italic> Disease in Mice","volume":"5","author":"D Almeida","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/AAC.45.11.3109-3112.2001","article-title":"Activities of new macrolides and fluoroquinolones against <italic>Mycobacterium ulcerans<\/italic> infection in mice","volume":"45","author":"A Bentoucha","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/AAC.44.9.2367-2372.2000","article-title":"Activities of several antimicrobials against <italic>Mycobacterium ulcerans<\/italic> infection in mice","volume":"44","author":"H Dega","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cid\/ciq072","article-title":"Oral Treatment for <italic>Mycobacterium ulcerans<\/italic> Infection: Results From a Pilot Study in Benin","volume":"52","author":"A Chauty","year":"2011","journal-title":"Clinical Infectious Diseases"},{"issue":"9715","key":"ref23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(09)61962-0","article-title":"Antimicrobial treatment for early, limited <italic>Mycobacterium ulcerans<\/italic> infection: a randomised controlled trial","volume":"375","author":"WA Nienhuis","year":"2010","journal-title":"The Lancet"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/AAC.02165-13","article-title":"Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of <italic>Mycobacterium ulcerans<\/italic> Disease","volume":"58","author":"RO Phillips","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(16)30274-2","article-title":"High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial","volume":"17","author":"MJ Boeree","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1164\/rccm.201410-1843OC","article-title":"Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial","volume":"191","author":"SE Dorman","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"139","key":"ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1183\/16000617.0080-2015","article-title":"Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials","volume":"25","author":"R Moodley","year":"2016","journal-title":"European Respiratory Review"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201204-0682OC","article-title":"The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment","volume":"186","author":"J van Ingen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/infdis\/171.3.747","article-title":"Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection","volume":"171","author":"RJ Wallace Jr.","year":"1995","journal-title":"The Journal of infectious diseases"},{"key":"ref30","article-title":"Pharmacokinetics of rifampicin and clarithromycin in patients treated for <italic>Mycobacterium ulcerans<\/italic> infection","author":"JW Alffenaar","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/AAC.00265-16","article-title":"Clofazimine Biocrystal Accumulation in Macrophages Upregulates Interleukin 1 Receptor Antagonist Production To Induce a Systemic Anti-Inflammatory State","volume":"60","author":"GS Yoon","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.15252\/embr.201744121","article-title":"Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells","volume":"18","author":"K Gharun","year":"2017","journal-title":"EMBO reports"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.201304-0753OC","article-title":"Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice","volume":"188","author":"JH Grosset","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1416951112","article-title":"Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis","volume":"112","author":"S Tyagi","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"ref35","first-page":"167","article-title":"Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966\u20131978","volume":"49","author":"SG Browne","year":"1981","journal-title":"International journal of leprosy and other mycobacterial diseases: official organ of the International Leprosy Association"},{"issue":"3","key":"ref36","first-page":"287","article-title":"Long-term clinical toxicity studies with clofazimine (B663) in leprosy","volume":"44","author":"RC Hastings","year":"1976","journal-title":"International journal of leprosy and other mycobacterial diseases: official organ of the International Leprosy Association"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4269\/ajtmh.1976.25.437","article-title":"Spaced clofazimine therapy of lepromatous leprosy","volume":"25","year":"1976","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5935\/0305-7518.19790020","article-title":"Lamprene (clofazimine) in leprosy. Basic information","volume":"50","author":"SJ Yawalkar","year":"1979","journal-title":"Leprosy review"},{"issue":"16","key":"ref39","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1517\/14656566.6.16.2867","article-title":"Clarithromycin extended-release in community-acquired respiratory tract infections","volume":"6","author":"KN Williams","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"ref40","unstructured":"U.S. Food and Drug Administration. Clarithromycin (Biaxin): Drug Safety Communication\u2014Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease. In: Services DoHaH, editor. 2018."}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006728","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T09:45:52Z","timestamp":1751795152000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006728"}},"subtitle":[],"editor":[{"given":"Pamela L. C.","family":"Small","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006728","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]}}}